In the present study, we have shown that blockage of CTLA-4 receptor on lymphocytes and concomitant reduction of CD4+CTLA-4+ and CD8+PD-1+ cells seem to be a crucial element in inhibition of MDA-MB-231 breast cancer cell proliferation and their arrest in the G1-phase. Here, CTLA4 is linked to breast cancer.